Larimar Therapeutics GAAP EPS of -$0.29 beats by $0.06
Tickers: $LRMR
Read the full article at Seeking Alpha
Part of the story Neumora Therapeutics Reports Q3 GAAP EPS of -$0.18, Exceeding Estimates (3 articles)
Tickers: $LRMR
Read the full article at Seeking Alpha
Part of the story Neumora Therapeutics Reports Q3 GAAP EPS of -$0.18, Exceeding Estimates (3 articles)